Intervention Protocol

Tramiprosate (Alzhemed) for Alzheimer's disease

  1. Reem Malouf1,*,
  2. Helen Collins2

Editorial Group: Cochrane Dementia and Cognitive Improvement Group

Published Online: 21 JAN 2009

DOI: 10.1002/14651858.CD007549


How to Cite

Malouf R, Collins H. Tramiprosate (Alzhemed) for Alzheimer's disease (Protocol). Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD007549. DOI: 10.1002/14651858.CD007549.

Author Information

  1. 1

    Cochrane Dementia and Cognitive Improvement Group, Oxford, UK

  2. 2

    Cochrane Dementia and Cognitive Improvement Group, Oxford University, Nuffield Department of Medicine, Oxford, Oxon, UK

*Reem Malouf, Cochrane Dementia and Cognitive Improvement Group, John Radcliffe Hospital (4th Floor, Room 4401C), Headington, Oxford, OX3 9DU, UK. reemmalouf@yahoo.com.

Publication History

  1. Publication Status: New
  2. Published Online: 21 JAN 2009

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To clearly define the clinical efficacy and safety of Tramiprosate for the treatment of Alzheimer's disease.